Hodgkin/Reed-Sternberg cells and Hodgkin's disease in patients with B-cellchronic lymphocytic leukaemia: an immunohistological, molecular and clinical study of four cases suggesting a heterogeneous pathogenetic background
E. Pescarmona et al., Hodgkin/Reed-Sternberg cells and Hodgkin's disease in patients with B-cellchronic lymphocytic leukaemia: an immunohistological, molecular and clinical study of four cases suggesting a heterogeneous pathogenetic background, VIRCHOWS AR, 437(2), 2000, pp. 129-132
Citations number
17
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
We report the immunohistological, molecular and clinical findings in four p
atients affected by B-cell chronic lymphocytic leukaemia (CLL) who develope
d "Richter's syndrome with Hodgkin's disease (HD) features" or "CLL with Ho
dgkin's transformation", all characterised by the presence of typical Hodgk
in / Reed-Sternberg (H/RS) cells in lymph node biopsies. In three cases the
nodal involvement by CLL was demonstrated both by the presence of a predom
inant background of CD5/CD19/CD23+ small lymphocytes and an IgH monoclonal
rearrangement revealed by PCR analysis. Conversely, in the remaining case t
here was neither immunohistological nor molecular evidence of lymph node in
volvement by CLL, In all four cases H/RS cells were Epstein-Barr virus (EBV
) latent membrane protein (LMP-1) positive. These findings suggest that the
presence of H/RS cells in the first three patients, who had CLL/HD nodal i
nvolvement, might be related to transformation or clonal evolution of CLL c
ells in H/RS cells, which is in keeping with use of the term "CLL with Hodg
kin's transformation". In the fourth case a de novo HD may be postulated, r
epresenting a second malignancy presumably not clonally related to CLL. In
all cases a key pathogenetic role of EBV is suggested by the expression of
LMP-1 in H/RS cells. Our findings indicate that the presence of typical H/R
S cells in lymph node biopsies in CLL patients may reflect a heterogeneous
pathogenetic background. The different clinico-pathologic settings should b
e taken into consideration because of their possible implications for patie
nts' treatment and prognosis.